CRA Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,406
Closed -$325K 298
2025
Q4
$325K Sell
3,406
-410
-11% -$40.2K 0.04% 225
2025
Q3
$373K Buy
3,816
+47
+1% +$4.87K 0.05% 207
2025
Q2
$405K Buy
3,769
+278
+8% +$28.1K 0.06% 182
2025
Q1
$352K Buy
3,491
+545
+18% +$54.9K 0.06% 187
2024
Q4
$263K Buy
2,946
+105
+4% +$9.24K 0.05% 214
2024
Q3
$238K Buy
2,841
+117
+4% +$9.22K 0.04% 225
2024
Q2
$210K Buy
+2,724
New +$199K 0.04% 239

Other funds holding BSX

CRA Financial Services's BSX Position: Q1 2026 in Review

CRA Financial Services sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,406 shares — an estimated $325K sold.

CRA Financial Services first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $405K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • CRA Financial Services reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • CRA Financial Services sold 3,406 Boston Scientific shares in Q1 2026, an estimated $325K.
  • CRA Financial Services first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
  • CRA Financial Services's Boston Scientific position peaked at $405K in Q2 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on CRA Financial Services's 13F filing for Q1 2026, filed 9 Apr 2026.